CAAS Capital Management’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
Other funds holding CELL
AIM
SUT
FAM
CAAS Capital Management's CELL Position: Q2 2021 in Review
CAAS Capital Management sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2021, closing a stake of 557,967 shares — an estimated $28M sold.
CAAS Capital Management first reported a position in CELL in Q3 2020 and held it in 3 quarters. The position peaked at $28M in Q1 2021. 156 funds tracked by Wall St. Rank hold CELL as of Q2 2021.
- CAAS Capital Management reported no remaining PhenomeX Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
- CAAS Capital Management sold 557,967 PhenomeX Inc. Common Stock shares in Q2 2021, an estimated $28M.
- CAAS Capital Management first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 3 quarters.
- CAAS Capital Management's PhenomeX Inc. Common Stock position peaked at $28M in Q1 2021.
- 156 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2021.
Based on CAAS Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.